| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Clinical Chemistry, Vol 33, 2267-2271, Copyright © 1987 by American Association for Clinical Chemistry
A method for measuring glycated hemoglobin (Hb A1c) and an accompanying method of specimen transport to a central laboratory were developed for the multicenter Diabetes Control and Complications Trial (DCCT). In the DCCT, results for Hb A1c are used to assess chronic glycemic control for data collection and patient management. During the feasibility phase of the trial, central (CHL) and backup laboratories using automated, "high-performance" ion-exchange liquid-chromatographic methods were established. Whole-blood samples were stored (4 degrees C) at each of the 21 clinical centers for up to 72 h before air-express shipment to the CHL. Quality-control procedures included daily analyses of three calibration specimens. A pooled hemolysate was assayed frequently over time as a long-term quality control (LTQC). After 18 months, within- and between-run CVs were less than 6%. Mean values for split duplicate samples assayed in a masked fashion at the CHL were nearly identical. LTQC results indicated no significant assay drift over time. More than 6000 samples were assayed (mean interval between obtaining the blood sample and completing the assay: less than six days). Hb A1c evidently can be precisely and reliably measured in the context of a long-term, multicenter trial such as the DCCT.
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  R. Kahn and V. Fonseca Translating the A1C Assay Diabetes Care, August 1, 2008; 31(8): 1704 - 1707. [Full Text] [PDF]
|
|
|
|
|
|
A. Herbst, O. Kordonouri, K. O. Schwab, F. Schmidt, R. W. Holl, and on behalf of the DPV Initiative of the German Work Impact of Physical Activity on Cardiovascular Risk Factors in Children With Type 1 Diabetes: A multicenter study of 23,251 patients Diabetes Care, August 1, 2007; 30(8): 2098 - 2100. [Full Text] [PDF]
|
|
|
|
 |
|
 I. H. de Boer, S. D. Sibley, B. Kestenbaum, J. N. Sampson, B. Young, P. A. Cleary, M. W. Steffes, N. S. Weiss, J. D. Brunzell, and for the Diabetes Control and Complications Trial/E Central Obesity, Incident Microalbuminuria, and Change in Creatinine Clearance in the Epidemiology of Diabetes Interventions and Complications Study J. Am. Soc. Nephrol., January 1, 2007; 18(1): 235 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Herbst, R. Bachran, T. Kapellen, R. W. Holl, and for the DPV Science Initiative Effects of Regular Physical Activity on Control of Glycemia in Pediatric Patients With Type 1 Diabetes Mellitus Arch Pediatr Adolesc Med, June 1, 2006; 160(6): 573 - 577. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. McCarter, J. M. Hempe, and S. A. Chalew Mean Blood Glucose and Biological Variation Have Greater Influence on HbA1c Levels Than Glucose Instability: An analysis of data from the Diabetes Control and Complications Trial Diabetes Care, February 1, 2006; 29(2): 352 - 355. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 The Diabetes Control and Complications Trial/Epide Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes N. Engl. J. Med., December 22, 2005; 353(25): 2643 - 2653. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Pontiroli, F. Folli, M. Paganelli, G. Micheletto, P. Pizzocri, P. Vedani, F. Luisi, L. Perego, A. Morabito, and S. Bressani Doldi Laparoscopic Gastric Banding Prevents Type 2 Diabetes and Arterial Hypertension and Induces Their Remission in Morbid Obesity: A 4-year case-controlled study Diabetes Care, November 1, 2005; 28(11): 2703 - 2709. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Genuth, W. Sun, P. Cleary, D. R. Sell, W. Dahms, J. Malone, W. Sivitz, V. M. Monnier, and for the DCCT Skin Collagen Ancillary Study Group Glycation and Carboxymethyllysine Levels in Skin Collagen Predict the Risk of Future 10-Year Progression of Diabetic Retinopathy and Nephropathy in the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications Participants With Type 1 Diabetes Diabetes, November 1, 2005; 54(11): 3103 - 3111. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Steffes, P. Cleary, D. Goldstein, R. Little, H.-M. Wiedmeyer, C. Rohlfing, J. England, J. Bucksa, M. Nowicki, and the DCCT/EDIC Research Group Hemoglobin A1c Measurements over Nearly Two Decades: Sustaining Comparable Values throughout the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications Study Clin. Chem., April 1, 2005; 51(4): 753 - 758. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Goldstein, R. R. Little, R. A. Lorenz, J. I. Malone, D. Nathan, C. M. Peterson, and D. B. Sacks Tests of Glycemia in Diabetes Diabetes Care, July 1, 2004; 27(7): 1761 - 1773. [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Williams Jr., W. Katon, E. H.B. Lin, P. H. Noel, J. Worchel, J. Cornell, L. Harpole, B. A. Fultz, E. Hunkeler, V. S. Mika, et al. The Effectiveness of Depression Care Management on Diabetes-Related Outcomes in Older Patients Ann Intern Med, June 15, 2004; 140(12): 1015 - 1024. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. McCarter, J. M. Hempe, R. Gomez, and S. A. Chalew Biological Variation in HbA1c Predicts Risk of Retinopathy and Nephropathy in Type 1 Diabetes Diabetes Care, June 1, 2004; 27(6): 1259 - 1264. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. Lyons, A. J. Jenkins, D. Zheng, D. T. Lackland, D. McGee, W. T. Garvey, and R. L. Klein Diabetic Retinopathy and Serum Lipoprotein Subclasses in the DCCT/EDIC Cohort Invest. Ophthalmol. Vis. Sci., March 1, 2004; 45(3): 910 - 918. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Q. Purnell, R. K. Dev, M. W. Steffes, P. A. Cleary, J. P. Palmer, I. B. Hirsch, J. E. Hokanson, and J. D. Brunzell Relationship of Family History of Type 2 Diabetes, Hypoglycemia, and Autoantibodies to Weight Gain and Lipids With Intensive and Conventional Therapy in the Diabetes Control and Complications Trial Diabetes, October 1, 2003; 52(10): 2623 - 2629. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Fineman, T. A. Bicsak, L. Z. Shen, K. Taylor, E. Gaines, A. Varns, D. Kim, and A. D. Baron Effect on Glycemic Control of Exenatide (Synthetic Exendin-4) Additive to Existing Metformin and/or Sulfonylurea Treatment in Patients With Type 2 Diabetes Diabetes Care, August 1, 2003; 26(8): 2370 - 2377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
The Diabetes Control and Complications Trial/Epide Intensive Diabetes Therapy and Carotid Intima-Media Thickness in Type 1 Diabetes Mellitus N. Engl. J. Med., June 5, 2003; 348(23): 2294 - 2303. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Jenkins, T. J. Lyons, D. Zheng, J. D. Otvos, D. T. Lackland, D. McGee, W. T. Garvey, R. L. Klein, and The DCCT/EDIC Research Group Serum Lipoproteins in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Intervention and Complications Cohort: Associations with gender and glycemia Diabetes Care, March 1, 2003; 26(3): 810 - 818. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Pontiroli, P. Pizzocri, M. C. Librenti, P. Vedani, M. Marchi, E. Cucchi, C. Orena, M. Paganelli, M. Giacomelli, G. Ferla, et al. Laparoscopic Adjustable Gastric Banding for the Treatment of Morbid (Grade 3) Obesity and its Metabolic Complications: A Three-Year Study J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3555 - 3561. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. L. Booth, B. Zinman, and D. A. Redelmeier Diabetes Care in the U.S. and Canada Diabetes Care, July 1, 2002; 25(7): 1149 - 1153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Mauer and K. Drummond The Early Natural History of Nephropathy in Type 1 Diabetes: I. Study Design and Baseline Characteristics of the Study Participants Diabetes, May 1, 2002; 51(5): 1572 - 1579. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. B. Sacks, D. E. Bruns, D. E. Goldstein, N. K. Maclaren, J. M. McDonald, and M. Parrott Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus Clin. Chem., March 1, 2002; 48(3): 436 - 472. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
The Diabetes Control and Complications Trial Resea Influence of Intensive Diabetes Treatment on Body Weight and Composition of Adults With Type 1 Diabetes in the Diabetes Control and Complications Trial Diabetes Care, October 1, 2001; 24(10): 1711 - 1721. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Phillipov and P. J. Phillips Components of Total Measurement Error for Hemoglobin A1c Determination Clin. Chem., October 1, 2001; 47(10): 1851 - 1853. [Full Text] [PDF]
|
|
|
|
|
|
S. K. West, R. Klein, J. Rodriguez, B. Munoz, A. T. Broman, R. Sanchez, and R. Snyder Diabetes and Diabetic Retinopathy in a Mexican-American Population: Proyecto VER Diabetes Care, July 1, 2001; 24(7): 1204 - 1209. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
The Diabetes Control and Complications Trial/Epide Retinopathy and Nephropathy in Patients with Type 1 Diabetes Four Years after a Trial of Intensive Therapy N. Engl. J. Med., February 10, 2000; 342(6): 381 - 389. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
The Diabetes Control and Complications Trial Resea The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus N. Engl. J. Med., September 30, 1993; 329(14): 977 - 986. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
